Uppsala, Sweden, April 3, 2013 / B3C newswire / – Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, has announced the launch of ISOLUTE® Myco SPE columns, a new product for the ‘catch and release’ clean up of mycotoxins from food matrices, prior to analysis by LC-MS/MS.
The ISOLUTE® Myco sorbent is a proprietary polymeric phase (patent pending) optimized for the extraction of a broad spectrum of mycotoxins from a wide range of foodstuffs; enabling chemists to utilize a single SPE product to extract all relevant mycotoxins from an individual foodstuff. Using a single, easy to use sample preparation product, along with optimized matrix specific application notes, scientists can prepare diverse samples for analysis by LC-MS/MS.
ISOLUTE® Myco SPE columns have been developed for use together with LC-MS/MS analysis, their selective clean up enables robust, reliable quantitation of mycotoxins without compromising analytical data quality. The coupling of a dedicated polymer based sorbent with LC-MS/MS analysis saves both time and money as more samples can be processed each day compared to IAC based clean up. The tabless 3 mL format of the ISOLUTE® Myco columns is suitable for a variety of processing equipment including vacuum manifolds, positive pressure manifolds and automated SPE workstations.
“ISOLUTE® Myco SPE columns are a real step forward in mycotoxin sample preparation, helping scientists to fully exploit the advantages of higher productivity and highly selective LC-MS/MS analysis through the use of a truly optimized sample preparation regime” says Dr. Claire Desbrow, Global Product Manager.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.
About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 462.9 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
For further press information from Biotage please contact:
James Churchill
Marketing Communications
Biotage GB Ltd.
Distribution Way
Dyffryn Business Park
Ystrad Mynach
Hengoed, Wales CF82 7TS
United Kingdom
Tel: +44 (0)1443 811 849
Mobile: +44(0)7875484778
Email: [email protected]